France Blood Plasma Derivative Market (2025-2031) | Analysis, Growth, Value, Industry, Size & Revenue, Forecast, Share, Trends, Outlook, Competitive Landscape, Companies, Segmentation

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 France Country Macro Economic Indicators

3.2 France Blood Plasma Derivative Market Revenues & Volume, 2021 & 2031F

3.3 France Blood Plasma Derivative Market - Industry Life Cycle

3.4 France Blood Plasma Derivative Market - Porter's Five Forces

3.5 France Blood Plasma Derivative Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 France Blood Plasma Derivative Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 France Blood Plasma Derivative Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of chronic diseases requiring plasma-derived therapies

4.2.2 Growing geriatric population in France

4.2.3 Technological advancements in plasma fractionation processes

4.2.4 Rising demand for immunoglobulins and coagulation factors

4.2.5 Favorable government regulations supporting plasma collection and processing

4.3 Market Restraints

4.3.1 High cost associated with plasma-derived therapies

4.3.2 Stringent regulatory requirements for plasma collection and processing

4.3.3 Limited plasma collection centers leading to supply shortages

4.3.4 Competition from alternative therapies

4.3.5 Concerns regarding the safety and efficacy of plasma-derived products

6.1 France Blood Plasma Derivative Market, By Type

6.1.1 Overview and Analysis

6.1.2 France Blood Plasma Derivative Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 France Blood Plasma Derivative Market Revenues & Volume, By Albumin, 2021- 2031F

6.1.4 France Blood Plasma Derivative Market Revenues & Volume, By Factor VII, 2021- 2031F

6.1.5 France Blood Plasma Derivative Market Revenues & Volume, By Factor IX concentrate, 2021- 2031F

6.1.6 France Blood Plasma Derivative Market Revenues & Volume, By Anti-coagulation factor, 2021- 2031F

6.1.7 France Blood Plasma Derivative Market Revenues & Volume, By Rh immunoglobulin, 2021- 2031F

6.1.8 France Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F

6.2 France Blood Plasma Derivative Market, By Application

6.2.1 Overview and Analysis

6.2.2 France Blood Plasma Derivative Market Revenues & Volume, By Immunodeficiency Diseases, 2021- 2031F

6.2.3 France Blood Plasma Derivative Market Revenues & Volume, By Bleeding Disorders, 2021- 2031F

6.2.4 France Blood Plasma Derivative Market Revenues & Volume, By Liver Conditions, 2021- 2031F

6.2.5 France Blood Plasma Derivative Market Revenues & Volume, By Others, 2021- 2031F

6.3 France Blood Plasma Derivative Market, By End User

6.3.1 Overview and Analysis

6.3.2 France Blood Plasma Derivative Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.3 France Blood Plasma Derivative Market Revenues & Volume, By Clinics, 2021- 2031F

6.3.4 France Blood Plasma Derivative Market Revenues & Volume, By Transfusion Centers, 2021- 2031F

7.1 France Blood Plasma Derivative Market Export to Major Countries

7.2 France Blood Plasma Derivative Market Imports from Major Countries

8.1 Average selling price of plasma-derived products

8.2 Number of plasma collection centers in France

8.3 Research and development investments in plasma fractionation technologies

8.4 Patient access to plasma-derived therapies

8.5 Number of adverse events reported related to plasma-derived products

9.1 France Blood Plasma Derivative Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 France Blood Plasma Derivative Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 France Blood Plasma Derivative Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 France Blood Plasma Derivative Market Revenue Share, By Companies, 2024

10.2 France Blood Plasma Derivative Market Competitive Benchmarking, By Operating and Technical Parameters